HR - HR lysine demethylase and nuclear receptor corepressor Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 397617
HR Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001083930.1 | NP_001077399.1 | lysine-specific demethylase hairless |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
lysine-specific demethylase hairless |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(14)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-50767 | Palbociclib | Inhibitor | 99.94% | Unkown |
| HY-50767C | Palbociclib hydrochloride | Inhibitor | 99.96% | Unkown |
| HY-50767A | Palbociclib monohydrochloride | Inhibitor | 99.98% | Unkown |
| HY-A0065 | Palbociclib isethionate | Inhibitor | 99.98% | Unkown |
| HY-A0088A | Cefotaxime | Inhibitor | 98.74% | Unkown |
| HY-114778 | Fluzoparib | Inhibitor | 99.96% | Unkown |
| HY-A0088 | Cefotaxime sodium | Inhibitor | 99.12% | Unkown |
| HY-B1824 | Cefpirome sulfate | Inhibitor | 99.49% | Unkown |
| HY-B1824R | Cefpirome sulfate (Standard) | Inhibitor | 99.04% | Unkown |
| HY-50767AR | Palbociclib monohydrochloride (Standard) | Inhibitor | 99.95% | Unkown |
| HY-50767B | Palbociclib dihydrochloride | Inhibitor | / | Unkown |
| HY-50767D | Palbociclib orotate | Inhibitor | / | Unkown |
| HY-B1448A | Benidipine | Inhibitor | / | Unkown |
| HY-B0699 | Cefpirome | / | Unkown |
Clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-171689 | Puxitatug samrotecan | Inhibitor | 98.51% | Phase 2 |
| HY-106380 | Glenvastatin | Inhibitor | / | Phase 2 |
| HY-19224 | Fonsartan | Antagonist | / | Phase 2 |
| HY-182468 | OP-3136 | Degrader | 99.90% | Phase 1 |
| HY-115552 | Simmiparib | Inhibitor | 99.01% | Phase 1 |
| HY-183118 | CID-078 | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(64)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-W187305 | MASM7 | 99.85% | Unkown | |
| HY-116770 | PFM01 | Inhibitor | 99.91% | Unkown |
| HY-159646 | BMS-986397 | 99.76% | Unkown | |
| HY-N0272 | Eleutheroside E | Inhibitor | 99.60% | Unkown |
| HY-148226 | 20-5,14-HEDGE | 99.28% | Unkown | |
| HY-147831 | HR-19011 | 99.64% | Unkown | |
| HY-148078 | PFM03 | Inhibitor | 99.86% | Unkown |
| HY-N0252 | Catharanthine | Inhibitor | 99.46% | Unkown |
| HY-170442 | ECI830 | Inhibitor | 98.01% | Unkown |
| HY-161430 | RTx-161 | 98.0% | Unkown | |
| HY-101813 | Laflunimus | Inhibitor | 99.70% | Unkown |
| HY-161431 | RTx-152 | 99.71% | Unkown | |
| HY-162384 | EPIC-0628 | Inhibitor | 98.66% | Unkown |
| HY-126972A | RI(dl)-2 TFA | Inhibitor | 98.8% | Unkown |
| HY-P2717 | Ac-YVAD-AMC | Inhibitor | 99.64% | Unkown |
| HY-45661 | Inixaciclib | Inhibitor | 99.93% | Unkown |
| HY-W654101 | Cefotaxime-d3 | Inhibitor | 98.00% | Unkown |
| HY-180573 | ART5537 | Inhibitor | 99.84% | Unkown |
| HY-P10895 | HR97 TFA | 99.00% | Unkown | |
| HY-181557 | SY-589 | 98.50% | Unkown | |
| HY-171159 | MC-Val-Cit-PAB-Sunitinib | 98.25% | Unkown | |
| HY-175812 | MU876 | Inhibitor | / | Unkown |
| HY-N0252A | Catharanthine Tartrate | Inhibitor | 98.88% | Unkown |
| HY-N0252B | Catharanthine Sulfate | Inhibitor | / | Unkown |
| HY-W052011 | Ruzinurad | Inhibitor | 99.26% | Unkown |
| HY-P3492 | SARS-CoV-2-IN-34 | Inhibitor | / | Unkown |
| HY-105879 | Tepirindole | / | Unkown | |
| HY-105907 | Perafensine | Inducer | / | Unkown |
| HY-106076 | REV 2871 | Inhibitor | / | Unkown |
| HY-115447 | Clobenpropit | Antagonist | / | Unkown |
| HY-117715 | CK-3197 | Inhibitor | / | Unkown |
| HY-126972 | RI(dl)-2 | Inhibitor | / | Unkown |
| HY-129934S | Latanoprost ethyl amide-d4 | / | Unkown | |
| HY-144338 | PARP1/BRD4-IN-1 | Inhibitor | / | Unkown |
| HY-144773A | Loxoprofenol-SRS tromethamine | Inhibitor | / | Unkown |
| HY-146194 | NHEJ inhibitor-1 | Activator | / | Unkown |
| HY-149972 | Antitumor agent-96 | Inducer | / | Unkown |
| HY-158733 | HR68 | / | Unkown | |
| HY-159091 | HIV-1 integrase inhibitor 12 | Inhibitor | / | Unkown |
| HY-162376 | T3SS-IN-4 | Inhibitor | / | Unkown |
| HY-163090 | HR488B | / | Unkown | |
| HY-168923 | HR-568 | Inhibitor | / | Unkown |
| HY-175466 | BER-IN-1 | / | Unkown | |
| HY-175482 | PARP1-IN-43 | Inhibitor | / | Unkown |
| HY-179413 | Polθ-IN-9 | Inhibitor | / | Unkown |
| HY-181026 | RP-4029 | Inhibitor | / | Unkown |
| HY-181611 | Polθ-IN-10 | / | Unkown | |
| HY-181840 | MU262 | Inhibitor | / | Unkown |
| HY-183285 | PI3Kα-IN-32 | Inhibitor | / | Unkown |
| HY-183748 | XL-20 | / | Unkown | |
| HY-P10804 | PIH | Inhibitor | / | Unkown |
| HY-P1807 | Mast Cell Degranulating Peptide HR-2 | / | Unkown | |
| HY-P5398 | HR2-18 | Inhibitor | / | Unkown |
| HY-P5497 | C34 peptide | Inhibitor | / | Unkown |
| HY-P5727 | HR1 | Inhibitor | / | Unkown |
| HY-RS06353 | HR Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-124823 | Monastroline | Inhibitor | / | Unkown |
| HY-157322 | SAV13 | / | Unkown | |
| HY-170775 | AChE-IN-83 | Inhibitor | / | Unkown |
| HY-A0088S | Cefotaxime-d3 sodium | Inhibitor | / | Unkown |
| HY-RS16724 | Hr Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23160 | Hr Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W654305 | Palbociclib-d4 | Inhibitor | / | Unkown |
| HY-W744633 | Cefdaloxime | Inhibitor | / | Unkown |